RE:RE:RE:RE:RE:RE:RE:RE:RE:Has anyone here done a background check on ..I was thinking $30M just from this particular pharma client over the next few years.
And then my question is why can't they execute such sales with more than a handful of their other F500 or F100 corporate accounts to eclipse $30m in annual revenues in not too distant future, accelerate growth, never look back and reach $100m in 3-5 years?
This last contract is a blessing and a curse for them. Blessing because it is one of the largest contracts they ever signed. A curse because it shows that those contracts are out there to be won so why are they not winning them more frequently.
I pretty well expect an NR every week on average leading up to the AGM that is not that far away anymore. Two weeks are covered by mandatory disclosure of financial results, so that provides them some contract announcement slack.
prone wrote: 30M...?
Why not sooner, reaching 30M via a lump of the PDAs being signed into contracts between todat and the AGM ................